p38 MAPK Activation Triggers Pharmacologically-induced &bgr; -adrenergic Preconditioning, but Not Ischaemic Preconditioning

By Marais E.   Genade S.   Strijdom H.   Moolman J.A.   Lochner A.  

Journal of Molecular and Cellular Cardiology, Vol. 33, Iss. 12, 2001-12 ,pp. : 2157-2177

Academic Press

Access to resources Recommend Favorite

p38 MAPK Activity is Not Increased Early During Sustained Coronary Artery Occlusion in Preconditioned Versus Control Rabbit Heart

By Gysembergh A.   Simkhovich B.Z.   Kloner R.A.   Przyklenk K.  

Journal of Molecular and Cellular Cardiology, Vol. 33, Iss. 4, 2001-04 ,pp. : 681-690

Academic Press

Access to resources Recommend Favorite

Phosphorylation State of hsp27 and p38 MAPK During Preconditioning and Protein Phosphatase Inhibitor Protection of Rabbit Cardiomyocytes

By Armstrong S.C.   delacey M.   Ganote C.E.  

Journal of Molecular and Cellular Cardiology, Vol. 31, Iss. 3, 1999-03 ,pp. : 555-567

Academic Press

Access to resources Recommend Favorite

Tumor necrosis factor-induced protection of the murine heart is independent of p38-MAPK activation

By Tanno M.   Gorog D.A.   Bellahcene M.   Cao X.   Quinlan R.A.   Marber M.S.  

Journal of Molecular and Cellular Cardiology, Vol. 35, Iss. 12, 2003-12 ,pp. : 1523-1527

Elsevier

Access to resources Recommend Favorite

Distinct roles of p42/p44^ERK and p38 MAPK in oxidant-induced AP-1 activation and cardiomyocyte hypertrophy

By Tu Victoria   Bahl Joe   Chen Qin  

Cardiovascular Toxicology, Vol. 3, Iss. 2, 2003-06 ,pp. : 119-133

Humana Press, Inc

Access to resources Recommend Favorite